AI brief of an SEC Form 8-K · Omega Healthcare Investors (OHI)

Omega Healthcare closes $2.3 billion credit facility, replacing $1.45 billion revolver

Neutral Impact 3 of 5 financing Written later

On September 30, 2025, Omega Healthcare Investors entered a new $2.3 billion senior unsecured credit facility, made up of a $2.0 billion revolver and a $300.0 million delayed draw term loan, and terminated its $1.45 billion 2021 revolving credit facility. The company also amended its $428.5 million term loan to reduce interest rate margins, and it had no borrowings outstanding under the new facility as of September 30, 2025.

Key points

  • New $2.0 billion revolving credit facility matures September 28, 2029; $300.0 million delayed draw term loan matures September 29, 2028.
  • Replaces the $1.45 billion 2021 revolving credit facility, which was scheduled to expire on October 30, 2025.
  • Term loan amendment cut interest rate margins by 35 basis points and removed the 0.100% step-up in extension periods.
  • Facility includes an accordion feature allowing total borrowing capacity of up to $3.0 billion; no borrowings were outstanding under the new facility as of September 30, 2025.

The filing

CompanyOmega Healthcare Investors (OHI)
Form8-K, current report
Filed with the SECOct 1, 2025, 10:23 AM ET
Accession number0000888491-25-000031

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.